Literature DB >> 10630499

Medical conditions in patients with pancreatic and biliary diseases: validity and agreement between data from questionnaires and medical records. PANKRAS II Study Group.

M Soler1, N Malats, M Porta, E Fernandez, L Guarner, A Maguire, J L Pinõl, J Rifà, A Carrato.   

Abstract

The aims of the study were to assess the agreement between data from personal interviews and medical records on selected medical conditions, to evaluate the validity of each source of information, and to estimate the prevalence of these conditions in pancreatobiliary pathology. Between 1992 and 1995, 602 patients with pancreatobiliary diseases were included in the PANKRAS II Study. Information from interview and medical records was available in 88% of cases. The agreement between both data sources was poor only for cholecystitis and mental disorders. The validity of both sources of information was high or acceptable for all conditions except for cholecystitis. Prevalence of past medical conditions was similar to that reported previously and varied according to diagnosis, gender, age, educational level, and hospital of admission. Research aimed at assessing the prevalence of less common diseases should consider subject- and health-related factors in collecting information.

Entities:  

Mesh:

Year:  1999        PMID: 10630499     DOI: 10.1023/a:1026635005363

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  37 in total

Review 1.  Agreement between questionnaire data and medical records. The evidence for accuracy of recall.

Authors:  S D Harlow; M S Linet
Journal:  Am J Epidemiol       Date:  1989-02       Impact factor: 4.897

2.  Behavior and interpretation of the kappa statistic: resolution of the two paradoxes.

Authors:  C A Lantz; E Nebenzahl
Journal:  J Clin Epidemiol       Date:  1996-04       Impact factor: 6.437

3.  Self-report and medical record report agreement of selected medical conditions in the elderly.

Authors:  T L Bush; S R Miller; A L Golden; W E Hale
Journal:  Am J Public Health       Date:  1989-11       Impact factor: 9.308

4.  Epidemiology for the uninitiated. Repeatability and validity.

Authors:  G Rose; D J Barker
Journal:  Br Med J       Date:  1978-10-14

5.  Pancreatitis and the risk of pancreatic cancer.

Authors:  E Fernandez; C La Vecchia; M Porta; E Negri; B d'Avanzo; P Boyle
Journal:  Pancreas       Date:  1995-08       Impact factor: 3.327

6.  Is questionnaire information valid in the study of a chronic disease such as diabetes? The Nord-Trøndelag diabetes study.

Authors:  K Midthjell; J Holmen; A Bjørndal; G Lund-Larsen
Journal:  J Epidemiol Community Health       Date:  1992-10       Impact factor: 3.710

7.  Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group.

Authors:  A B Lowenfels; P Maisonneuve; G Cavallini; R W Ammann; P G Lankisch; J R Andersen; E P Dimagno; A Andrén-Sandberg; L Domellöf
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

Review 8.  Epidemiology of pancreas cancer (1988).

Authors:  P Boyle; C C Hsieh; P Maisonneuve; C La Vecchia; G J Macfarlane; A M Walker; D Trichopoulos
Journal:  Int J Pancreatol       Date:  1989-12

9.  Pancreatitis is a risk factor for pancreatic cancer.

Authors:  P Bansal; A Sonnenberg
Journal:  Gastroenterology       Date:  1995-07       Impact factor: 22.682

10.  Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis.

Authors:  J Everhart; D Wright
Journal:  JAMA       Date:  1995 May 24-31       Impact factor: 56.272

View more
  9 in total

1.  Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage.

Authors:  Miquel Porta; Xavier Fabregat; Núria Malats; Luisa Guarner; Alfredo Carrato; Ana de Miguel; Laura Ruiz; Manuel Jariod; Sergi Costafreda; Susana Coll; Juan Alguacil; Josep M Corominas; Ricard Solà; Antonio Salas; Francisco X Real
Journal:  Clin Transl Oncol       Date:  2005-06       Impact factor: 3.405

2.  Timing of blood extraction in epidemiologic and proteomic studies: results and proposals from the PANKRAS II Study.

Authors:  Miquel Porta; José Pumarega; Olga Ferrer-Armengou; Tomàs López; Joan Alguacil; Núria Malats; Esteve Fernàndez
Journal:  Eur J Epidemiol       Date:  2007-07-18       Impact factor: 8.082

3.  Estimating dietary intakes from a brief questionnaire: A simulation study of reliability in a molecular epidemiologic study of pancreatic and biliary diseases.

Authors:  Michelle A Mendez; Jesús Vioque; Miquel Porta; Eva Morales; Tomàs López; Núria Malats; Marta Crous; Luis I Gómez
Journal:  Eur J Epidemiol       Date:  2006-07-08       Impact factor: 8.082

4.  Validity of the hospital discharge diagnosis in epidemiologic studies of biliopancreatic pathology. PANKRAS II Study Group.

Authors:  M Porta; S Costafreda; N Malats; L Guarner; M Soler; J M Gubern; E García-Olivares; M Andreu; A Salas; J M Corominas; J Alguacil; A Carrato; J Rifà; F X Real
Journal:  Eur J Epidemiol       Date:  2000-06       Impact factor: 8.082

5.  Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group.

Authors:  N Malats; T Casals; M Porta; L Guarner; X Estivill; F X Real
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

6.  Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: a prospective study in a clinically-relevant spectrum of patients.

Authors:  Lucy A Parker; Miquel Porta; Blanca Lumbreras; Tomàs López; Luisa Guarner; Ildefonso Hernández-Aguado; Alfredo Carrato; Josep M Corominas; Juli Rifà; Esteve Fernandez; Joan Alguacil; Núria Malats; Francisco X Real
Journal:  Eur J Epidemiol       Date:  2011-02-06       Impact factor: 8.082

7.  Concentrations of trace elements and KRAS mutations in pancreatic ductal adenocarcinoma.

Authors:  Álvaro Gómez-Tomás; José Pumarega; Juan Alguacil; André F S Amaral; Núria Malats; Natàlia Pallarès; Magda Gasull; Miquel Porta
Journal:  Environ Mol Mutagen       Date:  2019-05-23       Impact factor: 3.216

8.  Agreement between questionnaire and medical records on some health and socioeconomic problems among poisoning cases.

Authors:  Ahmed I Fathelrahman
Journal:  BMC Res Notes       Date:  2009-09-14

9.  Influence of KRAS mutations, persistent organic pollutants, and trace elements on survival from pancreatic ductal adenocarcinoma.

Authors:  Miquel Porta; José Pumarega; André F S Amaral; Jeanine M Genkinger; Judit Camargo; Lorelei Mucci; Juan Alguacil; Magda Gasull; Xuehong Zhang; Eva Morales; Mar Iglesias; Shuji Ogino; Lawrence S Engel
Journal:  Environ Res       Date:  2020-06-11       Impact factor: 6.498

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.